Z-1712-2017 Class III Terminated

Recalled by Siemens Healthcare Diagnostics, Inc. — Newark, DE

FDA device recall Z-1712-2017 was initiated by Siemens Healthcare Diagnostics, Inc. on Feb 23, 2017 and is designated Class III. Reason for recall: Siemens Healthcare Diagnostics has confirmed a positive bias of up to 41% in quality control and patient results for Aspartate Aminotransferase (AST) and Aspartate Aminotransferase concentrated… The recall status is terminated (terminated May 9, 2018). Affected quantity: 314 calibrators.

Recall details

Product Type
Devices
Report Date
Apr 12, 2017
Initiation Date
Feb 23, 2017
Termination Date
May 9, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
314 calibrators

Product description

ADVIA Chemistry Enzyme 2 Calibrator, multi-analyte mixture Product Usage: Assays included in Enzyme 2 Calibrator: AST, AST_c ALT, ALT_c, ALTP5P, ALTP_c, ASTP5P and ASTP_c

Reason for recall

Siemens Healthcare Diagnostics has confirmed a positive bias of up to 41% in quality control and patient results for Aspartate Aminotransferase (AST) and Aspartate Aminotransferase concentrated (AST_c) assays following calibration with Advia Chemistry Enzyme 2 Calibrator lots 6JD079 and 6MD042.

Distribution pattern

Worldwide Distribution - United States Nationwide: Denmark Sweden Norway Great Britain Belgium Netherlands Spain Israel Switzerland France Portugal Greece Germany Slovenia Czech Republic Hong Kong Colombia Korea Australia

Code information

Lots 6JD079 and 6MD042

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1712-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1712-2017. Report a data issue: hello@regdatalab.com.